DeepMed Research

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy

Phase 2

Recruiting

Conditions: Inflammatory Cardiomyopathy
Myocarditis

Interventions: Drug: Hydroxychloroquine
Drug: Prednisolone

First Posted Date: 2023-07-27

Last Posted Date: 2024-10-09

Lead Sponsor: Tongji Hospital

Target Recruit Count: 200

Registration Number: NCT05961202

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD

Phase 4

Recruiting

Conditions: Laryngopharyngeal Reflux

Interventions: Drug: Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets.
Drug: Jinsang Liyan Capsule placebo; Rabeprazole enteric-coated tablets.

First Posted Date: 2023-05-30

Last Posted Date: 2024-01-23

Lead Sponsor: Tongji Hospital

Target Recruit Count: 72

Registration Number: NCT05879029

Locations: 🇨🇳
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients

Not Applicable

Completed

Conditions: Colon Disease

Interventions: Drug: Remimazolam
Drug: Propofol

First Posted Date: 2023-04-06

Last Posted Date: 2024-08-13

Lead Sponsor: Tongji Hospital

Target Recruit Count: 114

Registration Number: NCT05801757

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Not Applicable

Conditions: Periampullary Adenocarcinoma

Interventions: Procedure: open pancreaticoduodenectomy
Procedure: laparoscopic pancreaticoduodenectomy

First Posted Date: 2023-03-28

Last Posted Date: 2025-04-09

Lead Sponsor: Tongji Hospital

Target Recruit Count: 210

Registration Number: NCT05788029

Locations: 🇨🇳
Department of Biliary and Pancreatic Surgery, Tongji Hospital, Affiliated Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan

Conditions: RSV Infection

Interventions: Other: Observation

First Posted Date: 2023-03-14

Last Posted Date: 2024-04-22

Lead Sponsor: Tongji Hospital

Target Recruit Count: 10000

Registration Number: NCT05767294

Locations: 🇨🇳
department of pediatrics, Tongji hospital, Tongji medical college, Huazhong University of Science and Technology, Wuhan, Hubei, China

A Liquid Biopsy Diagnostic Techniques for Endometriosis

Conditions: Endometriosis
Liquid Biopsy

First Posted Date: 2023-03-01

Last Posted Date: 2024-02-28

Lead Sponsor: Tongji Hospital

Target Recruit Count: 40

Registration Number: NCT05749341

Locations: 🇨🇳
Wenwen Wang, Wuhan, Hubei, China

Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients

Recruiting

Conditions: Immunosuppression
Kidney Transplant Infection
Kidney Transplant Rejection
Virus

First Posted Date: 2023-02-14

Last Posted Date: 2023-08-22

Lead Sponsor: Tongji Hospital

Target Recruit Count: 220

Registration Number: NCT05727709

Locations: 🇨🇳
The First Affiliated Hospital of Zhejiang University, Hangzhou, China
🇨🇳
Changhai Hospital affiliated to Naval Military Medical University, Shanghai, China
🇨🇳
the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

and more 2 locations

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Recruiting

Conditions: Hepatocellular Carcinoma Non-resectable

Interventions: Procedure: TACE
Drug: apatinib plus camrelizumab
Drug: Bevacizumab Biosimilar IBI305 plus sintilimab
Drug: Bevacizumab plus Atezolizumab
Drug: Lenvatinib
Drug: Anti-PD-1 monoclonal antibody
Drug: Donafenib
Drug: Sorafenib
Drug: Regorafenib

First Posted Date: 2023-02-08

Last Posted Date: 2024-06-13

Lead Sponsor: Tongji Hospital

Target Recruit Count: 300

Registration Number: NCT05717738

Locations: 🇨🇳
Optical Valley branch of Tongji hospital, Wuhan, Hubei, China
🇨🇳
The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China
🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

and more 1 locations

Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children

Not Applicable

Completed

Conditions: Drug Effect

Interventions: Drug: Esketamine
Drug: Remimazolam
Drug: Propofol
Drug: remifentanil

First Posted Date: 2023-01-17

Last Posted Date: 2023-08-21

Lead Sponsor: Tongji Hospital

Target Recruit Count: 106

Registration Number: NCT05686863

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer

Phase 1

Recruiting

Conditions: Ovarian Cancer

Interventions: Biological: KM1
Drug: Chemotherapy

First Posted Date: 2023-01-13

Last Posted Date: 2024-08-13

Lead Sponsor: Tongji Hospital

Target Recruit Count: 30

Registration Number: NCT05684731

Locations: 🇨🇳
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy